This trial is studying how well memory T helper type 2 cells work to initiate a recall response to aeroallergens in the lungs.
2 Primary · 0 Secondary · Reporting Duration: This is a single time point study with all information obtained at the time of bronchoscopy defined as Day 0.
Experimental Treatment
120 Total Participants · 1 Treatment Group
Primary Treatment: Bronchoscopy/BAL · No Placebo Group · N/A
Age 18 - 55 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: